Researchers Set to Launch Phase 3 Trial for Parkinson’s
A $23 million grant from the National Institutes of Health will support a new Phase 3 clinical trial to evaluate the drug isradipine as a potential new treatment for Parkinson’s disease. The study is being co-lead by the University of Rochester and Northwestern University Read More
Publications
Workflow Automation for a Virtual Hypertension Management Program
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network
Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID‐19 Pandemic
Carematix Unveils Revolutionary Cellular Weight Scale with Advanced Weight Asymmetry Technology
Carematix Launches the World’s First Connected Blinded Blood Pressure Monitor and Scale for Clinical Trials
Carematix launches remote patient monitoring scale
Innovaccer Partners With Carematix to Emphasize Remote Patient Monitoring on the Innovaccer Health Cloud
Carematix Chronic Care Monitoring Solution Helps Reduce Ochsner Hospital’s 30 Day Readmissions by 40%
